TARDBP and amyotrophic lateral sclerosis: The vast majority (>95%) of ALS and about half of FTD patients also share a common molecular histopathology, characterized by the mislocalization and aggregation of TDP-43 in the affected cells (Neumann et al., 2006; Lee et al., 2011).